Research Article
Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma
Table 4
Univariate and multivariate analyses of C2 expression for overall survival in HCC patients of the ICGC cohort.
| Variables | Univariate analysis | Multivariate analysis | Hazard ratio | 95% CI | value | Hazard ratio | 95% CI | value |
| Gender (male vs. female) | 0.51 | 0.28-0.97 | 0.04 | 0.43 | 0.23-0.81 | 0.01 | Age (>70 vs. ≤70) | 1.06 | 0.58-1.94 | 0.84 | | | | TNM stage (III+IV vs. I+II) | 2.38 | 1.30-4.36 | 0.004 | 2.59 | 1.39-4.80 | 0.003 | C2 (high vs. low) | 0.46 | 0.25-0.86 | 0.02 | 0.73 | 0.27-0.96 | 0.04 |
|
|